Supplementation with Ashitaba (Angelica keiskei) Yellow Stem Exudate Prevents Aging-Induced Thrombotic Tendencies and Systemic Inflammation Without Affecting Body Weight Gain in Mice

Angelica keiskei Koidzumi (Ashitaba) is a traditional folk medicine and health supplement in Japan. Ashitaba yellow stem exudate (AYE) contains abundant chalcones and thus has the potential to treat and prevent many pathological states such as cancer, inflammation, obesity, diabetics, thrombosis, and hypertension. Levels of plasminogen activator inhibitor 1 (PAI-1), a key regulator of the fibrinolytic system, increase with age in mouse plasma. Therefore, we aimed to determine the effects of AYE on plasma thrombotic parameters in aging mice. Long-term (52 weeks) AYE supplementation significantly decreased age-induced increases of PAI-1 in mouse plasma. Supplementation with AYE decreased levels of the acute-phase and fibrinolytic protein plasma plasminogen, and significantly decreased those of tumor necrosis factor α. These results suggested that continuous intake of AYE throughout life decreases age-induced systemic inflammation and prevents thrombotic tendencies without affecting body weight gain in aged mice. Our findings showed that supplementing diets with AYE might help to prevent thrombotic diseases in elderly individuals.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Journal of medicinal food - 26(2023), 11 vom: 07. Nov., Seite 843-848

Sprache:

Englisch

Beteiligte Personen:

Ohkura, Naoki [VerfasserIn]
Morimoto-Kamata, Riyo [VerfasserIn]
Oishi, Katsutaka [VerfasserIn]
Higo-Yamamoto, Sayaka [VerfasserIn]
Fujinami, Aya [VerfasserIn]
Inoue, Ken-Ichi [VerfasserIn]
Ohta, Mitsuhiro [VerfasserIn]

Links:

Volltext

Themen:

4-hydroxyderricin
Dietary supplement
Journal Article
PAI-1
Plasminogen Activator Inhibitor 1
Thrombosis
Xanthoangelol

Anmerkungen:

Date Completed 10.11.2023

Date Revised 10.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1089/jmf.2023.K.0140

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363543880